Payment overview · 2025
General Payments
$30.95
2 reported records · 2 companies
Healthcare provider profile · identity verified
Greg Smart, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · EL DORADO, AR · NPI 1073506010
Verified facts
What the public records show
CMS Open Payments records show Greg Smart, M.D. received $30.95 in general payments during 2025 across 2 reported records.
AstraZeneca Pharmaceuticals LP accounted for 54.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Farxiga.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BRILINTA as an associated drug or biological on 993 records involving 512 distinct recipient NPIs. Public Medicare Part D data also shows 32 claims for Brilinta by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 31 claims for Farxiga by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $16.97 | 54.8% | 1 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $13.98 | 45.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $30.95 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FARXIGA Normalized: farxiga |
Drug | AstraZeneca Pharmaceuticals LP | $16.97 | 1 | 2025 |
Source payment records
|
|||||
| Wegovy Normalized: wegovy |
Drug | Novo Nordisk Inc | $13.98 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| FARXIGA farxiga |
2025 | Farxiga | 2024 | 31 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | BRILINTA open payments reported associated product |
CMS Open Payments — General Payments 993 supporting records · 512 recipient NPIs · example record 1206131430 |
Brilinta · 2024 Exact normalized brand match · 1 Part D row |
32 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
31 | suppressed by CMS |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
15 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 659 | 130 |
| Levothyroxine Sodium | Levothyroxine Sodium | 553 | 101 |
| Amlodipine Besylate | Amlodipine Besylate | 541 | 119 |
| Potassium Chloride | Potassium Chloride | 488 | 90 |
| Eliquis | Apixaban | 474 | 54 |
| Furosemide | Furosemide | 414 | 70 |
| Metoprolol Tartrate | Metoprolol Tartrate | 413 | 85 |
| Gabapentin | Gabapentin | 410 | 77 |
| Pantoprazole Sodium | Pantoprazole Sodium | 339 | 83 |
| Tamsulosin Hcl | Tamsulosin Hcl | 314 | 64 |
| Losartan Potassium | Losartan Potassium | 312 | 85 |
| Simvastatin | Simvastatin | 290 | 60 |
| Clopidogrel | Clopidogrel Bisulfate | 287 | 62 |
| Sertraline Hcl | Sertraline Hcl | 282 | 61 |
| Metformin Hcl | Metformin Hcl | 233 | 44 |
| Carvedilol | Carvedilol | 198 | 33 |
| Donepezil Hcl | Donepezil Hcl | 178 | 28 |
| Tramadol Hcl | Tramadol Hcl | 172 | 55 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 171 | 70 |
| Hydrochlorothiazide | Hydrochlorothiazide | 150 | 29 |
| Allopurinol | Allopurinol | 146 | 25 |
| Lisinopril | Lisinopril | 136 | 26 |
| Omeprazole | Omeprazole | 132 | 30 |
| Trazodone Hcl | Trazodone Hcl | 132 | 33 |
| Memantine Hcl | Memantine Hcl | 127 | 17 |
| Montelukast Sodium | Montelukast Sodium | 118 | 22 |
| Mirtazapine | Mirtazapine | 112 | 22 |
| Metoprolol Succinate | Metoprolol Succinate | 111 | 32 |
| Jardiance | Empagliflozin | 102 | 16 |
| Hydralazine Hcl | Hydralazine Hcl | 99 | 23 |
| Prednisone | Prednisone | 94 | 58 |
| Xarelto | Rivaroxaban | 93 | 13 |
| Duloxetine Hcl | Duloxetine Hcl | 92 | 18 |
| Pioglitazone Hcl | Pioglitazone Hcl | 92 | 20 |
| Levetiracetam | Levetiracetam | 88 | 12 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 87 | 24 |
| Citalopram Hbr | Citalopram Hydrobromide | 86 | 14 |
| Alprazolam | Alprazolam | 85 | 29 |
| Baclofen | Baclofen | 81 | 12 |
| Glimepiride | Glimepiride | 81 | 17 |
| Sucralfate | Sucralfate | 80 | 14 |
| Spironolactone | Spironolactone | 79 | 15 |
| Escitalopram Oxalate | Escitalopram Oxalate | 78 | 21 |
| Buspirone Hcl | Buspirone Hcl | 77 | 15 |
| Fluticasone Propionate | Fluticasone Propionate | 67 | 20 |
| Amiodarone Hcl | Amiodarone Hcl | 66 | 20 |
| Nebivolol Hcl | Nebivolol Hcl | 63 | suppressed |
| Latanoprost | Latanoprost | 62 | 13 |
| Entresto | Sacubitril/Valsartan | 61 | suppressed |
| Clonazepam | Clonazepam | 60 | 14 |
| Finasteride | Finasteride | 56 | 11 |
| Ondansetron Hcl | Ondansetron Hcl | 54 | 29 |
| Azithromycin | Azithromycin | 53 | 39 |
| Propranolol Hcl | Propranolol Hcl | 53 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 53 | 11 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 51 | 46 |
| Doxycycline Hyclate | Doxycycline Hyclate | 51 | 44 |
| Oxybutynin Chloride | Oxybutynin Chloride | 49 | suppressed |
| Calcium Acetate | Calcium Acetate | 48 | suppressed |
| Gemtesa | Vibegron | 48 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 47 | suppressed |
| Lovastatin | Lovastatin | 47 | suppressed |
| Meloxicam | Meloxicam | 47 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 47 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 46 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 46 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 46 | suppressed |
| Celecoxib | Celecoxib | 45 | 11 |
| Clonidine Hcl | Clonidine Hcl | 45 | 13 |
| Divalproex Sodium | Divalproex Sodium | 44 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 43 | 12 |
| Alendronate Sodium | Alendronate Sodium | 42 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 41 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 40 | 12 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 39 | 16 |
| Dilantin | Phenytoin Sodium Extended | 39 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 39 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 38 | 31 |
| Lactulose | Lactulose | 37 | suppressed |
| Myrbetriq | Mirabegron | 37 | suppressed |
| Temazepam | Temazepam | 37 | 14 |
| Primidone | Primidone | 36 | suppressed |
| Propafenone Hcl | Propafenone Hcl | 36 | suppressed |
| Sotalol | Sotalol Hcl | 36 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 35 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 34 | 21 |
| Diltiazem Hcl | Diltiazem Hcl | 34 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 34 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 34 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 34 | suppressed |
| Atenolol | Atenolol | 33 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 33 | suppressed |
| Brilinta | Ticagrelor | 32 | suppressed |
| Bupropion Xl | Bupropion Hcl | 32 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 32 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 32 | 13 |
| Farxiga | Dapagliflozin Propanediol | 31 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 30 | suppressed |
| Levofloxacin | Levofloxacin | 30 | 25 |
| Vascepa | Icosapent Ethyl | 30 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 30 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 27 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 25 | suppressed |
| Estradiol | Estradiol | 25 | suppressed |
| Tradjenta | Linagliptin | 25 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 24 | suppressed |
| Bumetanide | Bumetanide | 24 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 24 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 24 | suppressed |
| Olanzapine | Olanzapine | 24 | suppressed |
| Fentanyl | Fentanyl | 23 | suppressed |
| Fluconazole | Fluconazole | 23 | 18 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 23 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 23 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 23 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 23 | suppressed |
| Ondansetron Odt | Ondansetron | 23 | 12 |
| Cephalexin | Cephalexin | 22 | 17 |
| Dicyclomine Hcl | Dicyclomine Hcl | 22 | suppressed |
| Famotidine | Famotidine | 22 | suppressed |
| Insulin Lispro | Insulin Lispro | 21 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 21 | suppressed |
| Synthroid | Levothyroxine Sodium | 21 | suppressed |
| Aripiprazole | Aripiprazole | 20 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 20 | 14 |
| Diazepam | Diazepam | 20 | suppressed |
| Ezetimibe | Ezetimibe | 20 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 20 | suppressed |
| Renvela | Sevelamer Carbonate | 20 | suppressed |
| Risperidone | Risperidone | 20 | suppressed |
| Amoxicillin | Amoxicillin | 19 | 15 |
| Irbesartan | Irbesartan | 19 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 19 | 12 |
| Glipizide | Glipizide | 18 | suppressed |
| Humalog | Insulin Lispro | 18 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 18 | suppressed |
| Torsemide | Torsemide | 18 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 17 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 17 | suppressed |
| Perindopril Erbumine | Perindopril Erbumine | 17 | suppressed |
| Telmisartan | Telmisartan | 17 | suppressed |
| Topiramate | Topiramate | 17 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 17 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 16 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 16 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 16 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 16 | suppressed |
| Gemfibrozil | Gemfibrozil | 16 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 15 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 15 | suppressed |
| Ozempic | Semaglutide | 15 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 15 | suppressed |
| Digoxin | Digoxin | 14 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 14 | suppressed |
| Nifedipine Er | Nifedipine | 14 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 14 | suppressed |
| Budesonide | Budesonide | 13 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 13 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 13 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Lansoprazole | Lansoprazole | 13 | suppressed |
| Lumigan | Bimatoprost | 13 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 13 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 13 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 13 | suppressed |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 12 | suppressed |
| Carbamazepine | Carbamazepine | 12 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 12 | suppressed |
| Descovy | Emtricitabine/Tenofov Alafenam | 12 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 12 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 12 | suppressed |
| Fingolimod | Fingolimod Hcl | 12 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 12 | suppressed |
| Jentadueto | Linagliptin/Metformin Hcl | 12 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 12 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 12 | 11 |
| Mesalamine | Mesalamine | 12 | suppressed |
| Multaq | Dronedarone Hcl | 12 | suppressed |
| Novolin R | Insulin Regular, Human | 12 | suppressed |
| Pentoxifylline | Pentoxifylline | 12 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 12 | suppressed |
| Tivicay | Dolutegravir Sodium | 12 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 11 | suppressed |
| Anastrozole | Anastrozole | 11 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 11 | suppressed |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 11 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 11 | suppressed |
| Leflunomide | Leflunomide | 11 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $30.95 · 2 records | AstraZeneca Pharmaceuticals LP | FARXIGA, Wegovy | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Farxiga play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error